Guardant Health
GH
$27.10
Share price
-1.35%
Change (1 day)
-13.67%
Change (1 year)
Categories
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.
Guardant Health (GH) - Total assets
Total assets on the balance sheet as of March 2024 : $1.70 B
According to Guardant Health 's latest financial reports the company's total assets are $1.70 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Guardant Health - Total assets on balance sheet (from 2017 to 2024)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $1.78 B | 10.96% |
| 2022-12-31 | $1.60 B | -26.97% |
| 2021-12-31 | $2.20 B | -2.96% |
| 2020-12-31 | $2.27 B | 136.02% |
| 2019-12-31 | $0.96 B | 63.86% |
| 2018-12-31 | $0.58 B | 71.29% |
| 2017-12-31 | $0.34 B | 194.2% |
| 2016-12-31 | $0.11 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Neogen NEOG | $4.58 B | 168.83% | 🇺🇸 USA |
 Natera NTRA | $1.46 B | -13.87% | 🇺🇸 USA |